AU2003232077A1 - Cyclic peptide anti-cancer agents and methods - Google Patents

Cyclic peptide anti-cancer agents and methods

Info

Publication number
AU2003232077A1
AU2003232077A1 AU2003232077A AU2003232077A AU2003232077A1 AU 2003232077 A1 AU2003232077 A1 AU 2003232077A1 AU 2003232077 A AU2003232077 A AU 2003232077A AU 2003232077 A AU2003232077 A AU 2003232077A AU 2003232077 A1 AU2003232077 A1 AU 2003232077A1
Authority
AU
Australia
Prior art keywords
methods
cyclic peptide
cancer agents
peptide anti
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003232077A
Other versions
AU2003232077A8 (en
Inventor
M. Reza Ghadiri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU2003232077A8 publication Critical patent/AU2003232077A8/en
Publication of AU2003232077A1 publication Critical patent/AU2003232077A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003232077A 2002-05-06 2003-05-06 Cyclic peptide anti-cancer agents and methods Abandoned AU2003232077A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37839502P 2002-05-06 2002-05-06
US60/378,395 2002-05-06
PCT/US2003/014373 WO2003092632A2 (en) 2002-05-06 2003-05-06 Cyclic peptide anti-cancer agents and methods

Publications (2)

Publication Number Publication Date
AU2003232077A8 AU2003232077A8 (en) 2003-11-17
AU2003232077A1 true AU2003232077A1 (en) 2003-11-17

Family

ID=29401603

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003232077A Abandoned AU2003232077A1 (en) 2002-05-06 2003-05-06 Cyclic peptide anti-cancer agents and methods

Country Status (2)

Country Link
AU (1) AU2003232077A1 (en)
WO (1) WO2003092632A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085777A2 (en) 2000-05-09 2001-11-15 Greenville Hospital System Therapeutic pore-forming peptides
US7456146B2 (en) * 2001-05-09 2008-11-25 Ghc Research Development Corporation Lytic peptide prodrugs
WO2010051667A1 (en) * 2008-11-10 2010-05-14 复旦大学 Pharmaceutical compositions comprising cyclic peptide nanotubes and the uses thereof
ES2342874B2 (en) * 2010-02-19 2011-01-27 Fundacio Privada Institut D'investigacio Biomedica De Girona Dr. Josep Trueta INHIBITING CYCLIC PEPTIDES OF CELLULAR GROWTH.
WO2013025099A1 (en) * 2011-08-17 2013-02-21 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Substrates for the detection of periopathogens of the oral cavity
CN104583229B (en) * 2012-08-29 2020-06-16 新加坡科技研究局 Peptides and uses thereof
CA2908552A1 (en) * 2013-04-02 2014-10-09 The Scripps Research Institute Uses of cyclic peptides for treating and preventing atherosclerosis
DK3149025T3 (en) 2014-05-21 2019-07-22 Entrada Therapeutics Inc CELL PENETRATING PEPTIDES AND METHODS FOR PRODUCING AND USING THEREOF
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
EP3185880B1 (en) 2014-08-27 2020-02-12 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
WO2016115140A1 (en) * 2015-01-13 2016-07-21 Boston Scientific Scimed, Inc. Cancer cell membrane depolarization
CN106699841B (en) * 2017-01-05 2020-07-24 北京大学深圳研究生院 Self-assembled polypeptide nanorod and preparation method thereof
EP3749365A4 (en) 2018-01-29 2022-01-12 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-nfat interaction
CA3092062A1 (en) 2018-02-22 2019-08-29 Entrada Therapeutics, Inc. Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
WO2019217682A1 (en) 2018-05-09 2019-11-14 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277818B1 (en) * 1998-10-29 2001-08-21 Angstrom Pharmaceuticals, Inc. Cyclic peptide ligands that target urokinase plasminogen activator receptor
US6096707A (en) * 1997-07-11 2000-08-01 Biotie Therapies Ltd. Integrin binding peptide and use thereof

Also Published As

Publication number Publication date
WO2003092632A3 (en) 2007-11-01
AU2003232077A8 (en) 2003-11-17
WO2003092632A2 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
WO2004040000A9 (en) G protein coupled receptors and uses thereof
AU2003212458A1 (en) Cyclo(n)pyrroles and methods thereto
AU2003270652A1 (en) Protein and peptide expression for passive immunity
AU2002364051A1 (en) Anti-cancer combination and use thereof
AU2003232077A1 (en) Cyclic peptide anti-cancer agents and methods
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003241384A1 (en) Cyclic peptide anti-viral agents and methods
AU2003211163A1 (en) Partial peptide mimetics and methods
AU2003272423A1 (en) Centrosome proteins and uses thereof
AU2003207628A1 (en) Structural and cytoskeleton-associated proteins
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003214038A1 (en) Peptides with anti-hypertensive properties
AU2003290886A1 (en) Modified alpha-msh peptides and derivatives thereof
AU2003247367A1 (en) Stimulation and injection system
AU2003218232A1 (en) Peptide analogues and uses thereof
AU2003220265A1 (en) Tamperproof and counterfeit-resistant structure
GB0317376D0 (en) Immunogenic protein and uses thereof
EP1699809A4 (en) Amniotic-derived peptide and uses thereof
AU2003216442A1 (en) Enkurin and uses thereof
AU2003303464A1 (en) Centrosome-associated protein and applications thereof
GB0228538D0 (en) Protein structure and uses thereof
AU2003270518A1 (en) Therapeutic anti-bgp(c-cam1) antibodies and uses thereof
AU2002952117A0 (en) Cyclic tetrapeptide compound and use thereof
AU2002232176A1 (en) Cyclic peptide
AU2003263751A1 (en) Novel proteins and their uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase